Georgia (PRWEB) July 24, 2013
When Dr. Jonas Salk invented the vaccine to poliomyelitis, he refused to patent it, and instead, he gave the cure away for free, refusing to make monetary gains from his creation due to his desire to better the world by ridding it of a debilitating disease. Unfortunately, similar acts of magnanimity are few and far between in the modern, corporate-dominated world, where pharmaceutical companies seek to profit from the sale of their products. In The Renaissance of Aspirin, author Glenn Parris takes this for-profit mindset to its logical extreme by weaving a story wherein a major pharmaceutical corporation attempts to use violent means to suppress a major medical discovery that promises to heal those suffering from fibromyalgia syndrome – at the expense of cutting down the company’s profit margins.
Anita Thomas and Jack Wheaton are young doctors employed in the creation of a corporation-patented antibody for the treatment of fibromyalgia syndrome. The new drug is effective, but dangerously flawed. The problem is that Anita has developed a cheaper and safe alternative agent that promises relief to those suffering from the disease. Naturally, after expenditure of a fortune in development, the pharmaceutical manufactures involved are not at all pleased with her. The plot unfolds as readers follow Anita and Jack from beautiful upscale midtown to the seedier downtown counterparts of Boston and Atlanta, their journey over shadowed by deadly stalkers and embellished by amorous, often comically frustrating misadventures.
At the thematic core of the tale is the idea that some, namely the powerful elite, consider profiting from a great scientific breakthrough to be more important than the good it can do for all of humanity, and how they even go out of their way to crush those who threaten their profits. The hope of a new medical discovery that will better countless lives becomes overshadowed by greed, as a sinister cabal goes to great lengths to hide its flaws. They are stymied when the protagonists of the story herald the rebirth of a solution to the disease devised eons ago by nature, to the chagrin of the conspirators, who then resort to violence to silence the heroes.
The Renaissance of Aspirin is peppered with industrial espionage, suspense and passion as the chase is on for the first cure for fibromyalgia. Anita and Jack barely keep ahead of the treacherous cabal of nemeses: Luciana Velasquez and Jason Brasil led by the Über-villain, Orson Quirk. Paced in the tradition of John Grisham’s The Pelican Brief, or a contemporary Maltese Falcon, The Renaissance of Aspirin is both plot and character driven, with a credible McGuffin at its core. These complex characters are funny, mean, desperate, lonely and at the same time very humanly imperfect. Readers will find their prickly exploits thoroughly entertaining.
For more information on this book, interested parties may log on to http://www.Xlibris.com.
About the Author
As a board certified rheumatologist, Glenn Parris has practiced medicine in the northeast Atlanta suburbs for over 20 years. He has been writing for nearly as long. Originally from New York City, Parris migrated south to escape the cold and snow, but fell in love with the southern charms of Georgia and Carla, his wife of 22 years. He now writes cross-genre in medical mystery, science fiction, fantasy, and historical fiction. The Renaissance of Aspirin is his debut novel.
The Renaissance of Aspirin * by Glenn Parris
Publication Date: May 16, 2013
Trade Paperback; $18.99; 403 pages; 978-1-4836-3302-2
Trade Hardback; $26.99; 403 pages; 978-1-4836-3303-9
eBook; $3.99; 978-1-4836-3301-5
Members of the media who wish to review this book may request a complimentary paperback copy by contacting the publisher at (888) 795-4274 x. 7879. To purchase copies of the book for resale, please fax Xlibris at (812) 355-4079 or call (888) 795-4274 x. 7879. For more information on self-publishing or marketing with Xlibris, visit http://www.Xlibris.com. To receive a free publishing guide, please call (888) 795-4274.